UNSPSC 51141555: Dulozafone

This classification denotes an anticonvulsant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BK2633656Q. European Medicines Agency schedules Dulozafone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06425MIG. Dulozafone generally arises in the molecular formula C20H22CL2N2O4. The term DULOZAFONE is an International Non-Proprietary Name or INN. DULOZAFONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule dulozafone under HS 29242995 and SITC 51479. As of Q4 2014, DULOZAFONE remains the US FDA Preferred Term for this commodity. Dulozafone bears US NLM identifiers UMLS ID C0642769 and NCI Concept Code C65497. SMILES: CLC1CC(C(N(C(=O)CN(CCO)CCO)C)CC1)C(=O)C1C(CL)CCCC1.

UNSPSC 51141555 Dulozafone is a Commodity code that appears in state and local procurement records with limited recent activity and a significant scope mismatch. The single recent opportunity posted under this code—Seminole County, Florida's IFB60459723LAS—solicits naloxone and safe drug deactivation systems for community health initiatives, not dulozafone pharmaceutical products. The procurement calls for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors must submit electronic bids through the county's e-Procurement Portal, include all shipping and delivery costs, provide unit pricing for each line item, comply with drug-free workplace and E-Verify requirements, and maintain workers' compensation, commercial general liability, and professional liability insurance. The contract structure includes an initial two-year term with a one-year renewal option and a three-month probationary period during which Seminole County may terminate with or without cause.

The code shows minimal recent state and local procurement activity tied to its nominal product definition. Seminole County, Florida is the only issuing body visible in the recent-opportunities block, and the scope of that single solicitation diverges substantially from dulozafone as named in the code itself. The IFB response deadline was July 26, 2023—a past date that reflects historical posting rather than active forward opportunity. Without additional recent solicitations or a pattern of issuing-body engagement under this code, dulozafone procurement does not present a clear market signal for business development targeting state and local buyers at this time.